Companies /Healthcare

Medtronic Plc

NYSE: MDT Medical Devices
$100.72
▼ $1.60 (−1.56%) today
Markets closed · 10:26pm ET

24/7 Wall St. View

MDT at a Glance

Valuation
Market cap
$130.9B
P/E ratio
25.1
Dividend yield
2.77%
Profitability
Revenue (TTM)
$37.5B
Profit margin
13.9%
EPS (TTM)
$4.07
Price
52-week range
$72 – $106
24/7 target
$120.38
Street target
$105.00
Earnings
Next report
Nov 24, 2026
Q1 2027 EPS
$1.45
vs. $1.39 est.
+4.5%

Headquartered in Building Two, Galway Fiscal year ends April NYSE: MDT medtronic.com

About Medtronic plc.

Medtronic plc is a global healthcare technology company that develops and manufactures medical devices and therapies across cardiovascular, neuroscience, medical surgical, and diabetes care. The company's portfolio spans cardiac devices (including pacemakers, defibrillators, cardiac ablation systems, and structural heart solutions), cranial and spinal surgical technologies, surgical robotics, neuromodulation therapies, patient monitoring systems, insulin pumps, and continuous glucose monitors. Medtronic serves healthcare systems in more than 150 countries with approximately 95,000 employees. The company is in the process of separating its Diabetes business through potential capital markets transactions, which may include a spin-off, split-off, or offering. In fiscal 2027, the Cardiovascular Portfolio was reorganized into Electrophysiology Therapies, Interventional Cardiology Therapies, CardioVascular Surgery, and Peripheral Vascular Health divisions. The company trades on the NYSE under the ticker MDT. Updated

Revenue by Segment · Q1 2027
  1. Cardiovascular Portfolio40%
  2. Neuroscience Portfolio27%
  3. Medical Surgical Portfolio23%
  4. Diabetes9%

Latest Activity

EWEdwards Lifesciences
52-week high
$107.19
+1.30%vs prior 52-week high · Nov 12, 2026

A second straight record close for the valve maker at $107.19, 1.3% above Thursday's peak. Medtronic rose 1.88% and Abbott 1.22% the same day, so the medtech bid was broad.

Related stockstoday
  • MDTMedtronic plc.Competitor+1.9%
    Dec 31, 2025 · SEC 10-K
  • ABTAbbott LaboratoriesCompetitor+1.2%
    Dec 31, 2025 · SEC 10-K
  • BDXBecton DickinsonPartner+1.1%
    Sep 30, 2025 · SEC 10-K

Moves: Nov 13, 2026 · Alpha Vantage daily close

MDTMedtronic plc.
New 52-week high$105.02+3.0% vs prior high · 2025-11-25

Medtronic just set a fresh 52-week high at $105.02, 2.97% above its prior peak from November 2025. The medtech giant has erased a spring slide that took it under $74.

MDTMedtronic plc.
Regular session
$104.81
+4.57%open $100.23

A 4.57% climb to $104.81 adds roughly $6 billion to a $134.1 billion medical-device giant, and megacaps this size rarely move that far in a single session. Keep an eye on whether it holds above the $100.23 open.

Mad Money w/ Jim Cramer 11/2/26

  • Oil's drop pulled long rates down, lifting Amazon, Capital One, JP Morgan, Costco and Walmart on no company news
  • Non-tech growth is where the money went: medical devices like Medtronic and Intuitive Surgical, plus staples Pepsi and P&G
  • Apple's record September quarter beat on iPhone and Mac, but Cramer expects the stock lower short term on guidance
  • Oracle filed to raise $20 billion days after saying it would limit raises; Intel seen losing PC share to AMD

The call is that falling long rates are repricing everything outside tech right now rather than earnings, and Cramer says growth stocks away from semis are the clean way to play it. He is warning Apple holders that guidance will disappoint even after a record quarter, and he is openly annoyed at Oracle for raising capital immediately after promising restraint.

Sold Medtronic plc$4.8M50,000 shares @ $95

Medtronic's CEO just took $4.75 million off the table, trimming 18% of his personal stake right after the company raised fiscal 2027 guidance. No 10b5-1 plan was disclosed on the filing, which makes it a discretionary sale.

Mad Money w/ Jim Cramer 10/14/26

  • Hot CPI, up 0.6% from August to September, plus rising oil leaves the next Fed move genuinely unclear
  • Bank stocks sold off on good quarters: Morgan Stanley dropped seven bucks, Citi and Wells Fargo found no footing
  • CoreWeave's slide and distressed neocloud debt are dragging on the broader tape
  • Amazon, Walmart and Costco seen as the retailers that would roll back prices if oil collapses

Cramer's point for anyone holding bank stocks: solid results are no longer being rewarded, and the charts have turned ugly regardless. The bigger swing factor is oil. If the war ends, he expects crude to be cut in half, which would reset inflation and the Fed debate overnight.

Mad Money w/ Jim Cramer 10/1/26

  • Cramer still buys Palantir at $190 after the stock gained 60% in Q3 and stalled short of his $250 target
  • Salesforce, up 46.5%, called the better SaaS-apocalypse rebound than Veeva at 30 times earnings
  • Caterpillar's 24% Q3 profit taking framed as a buying chance on data center engine demand
  • IBM, down 22% on its miss, gets the wait-a-quarter rule; Home Depot stays hostage to rates

Cramer wants to add software as the bounce-back trade and the beaten-down industrial names tied to data center power. He also warns that rising rates are the real threat heading into earnings season in a couple of weeks.

MDT Coverage

Frequently Asked Questions

What does Medtronic plc. do?

Medtronic plc is a global healthcare technology company that develops and manufactures medical devices and therapies across cardiovascular, neuroscience, medical surgical, and diabetes care.

What is the MDT stock price target?

24/7 Wall St.'s 12-month price target for MDT is $120.38, rated Buy. The Wall Street consensus target is $105.00. MDT price prediction →